Literature DB >> 8861279

Diagnosis and therapy of acute intermittent porphyria.

S Sassa1.   

Abstract

The porphyrias are a group of disorders caused by deficiencies in the activities of the enzymes of the heme biosynthetic pathway. As a result, abnormally elevated levels of porphyrins and/or their precursors, e.g. delta-aminolevulinic acid and porphobilinogen are produced in excess, accumulate in tissues, and are excreted in urine and stool. Two cardinal symptoms of the porphyrias are cutaneous photosensitivity and neurologic disturbances. Acute intermittent porphyria is the most important form of hepatic porphyria because of its frequency and severe clinical symptoms.

Entities:  

Mesh:

Year:  1996        PMID: 8861279     DOI: 10.1016/s0268-960x(96)90020-x

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  4 in total

Review 1.  Erythropoietic and hepatic porphyrias.

Authors:  U Gross; G F Hoffmann; M O Doss
Journal:  J Inherit Metab Dis       Date:  2000-11       Impact factor: 4.982

Review 2.  Porphyrias in Japan: compilation of all cases reported through 2002.

Authors:  Masao Kondo; Yuzo Yano; Masuo Shirataka; Gumpei Urata; Shigeru Sassa
Journal:  Int J Hematol       Date:  2004-06       Impact factor: 2.490

Review 3.  Recent advances in photodynamic diagnosis of gastric cancer using 5-aminolevulinic acid.

Authors:  Noriaki Koizumi; Yoshinori Harada; Takeo Minamikawa; Hideo Tanaka; Eigo Otsuji; Tetsuro Takamatsu
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 4.  Acute Intermittent Porphyria: Current Perspectives And Case Presentation.

Authors:  Zachary Spiritos; Shakirat Salvador; Diana Mosquera; Julius Wilder
Journal:  Ther Clin Risk Manag       Date:  2019-12-16       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.